Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 2 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 3 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 4 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 5 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 6 | Cell adhesion molecules 💬 14 genes, 22 drugs (DrugBank) and 35 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 7 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 8 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 9 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 10 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 11 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 12 | ECM-receptor interaction 💬 6 genes, 9 drugs (DrugBank) and 15 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 13 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 14 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 15 | Focal adhesion 💬 27 genes, 43 drugs (DrugBank) and 44 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 16 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 17 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 18 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 19 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 20 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 21 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 22 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 23 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 24 | Intestinal immune network for IgA production 💬 16 genes, 27 drugs (DrugBank) and 47 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 25 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 26 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 27 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 28 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 29 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGA4 2件: ITGA4, ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|
| 30 | Regulation of actin cytoskeleton 💬 28 genes, 60 drugs (DrugBank) and 63 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 31 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases |
ITGB7 1件: ITGB7 💬
|
Abrilumab Abrilumab 💬
| Abrilumab | 096 2件: 96, 97 💬
|
| 32 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases |
ITGB7 1件: ITGB7 💬
|
Etrolizumab Etrolizumab 💬
| Etrolizumab | 096 2件: 96, 97 💬
|
| 33 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases |
ITGB7 1件: ITGB7 💬
|
Vedolizumab Vedolizumab 💬
| Vedolizumab | 094 3件: 94, 96, 97 💬
|